[Other] Hope on the Horizon: Promising Therapies for Steatotic Liver Disease Closed
|
Reward20points
|
10
Design and rationale of a phase 1 dose-escalation study of AMG 193, a methylthioadenosine (MTA)-cooperative PRMT5 inhibitor, in patients with advanced methylthioadenosine phosphorylase (MTAP)-null solid tumors.
50
[Full book]Perovskite Optoelectronic Devices
20
How to Write an Abstract for Presentation at a Scientific Meeting
20
The Rise and Fall of Neoliberal Capitalism
10
[64Cu]Cu-FAP-NOX, a N-oxalyl modified cyclic peptide for FAP PET imaging with a flexible imaging time window.
